Product Information
FORTEO 560 MCG/2.24 ML PEN INJ is a brand product labeled by Eli Lilly and Company, priced at $1841.2749 per ML under NDC 00002967801. Its NADAC has been published 52 times since Oct 8, 2025.
FDA first approved this application on Nov 26, 2002. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the Teriparatide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 ug/mL
Manufacturer
Eli Lilly and CompanyNDC
00002967801
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
TERIPARATIDEApproval Type
New Drug (NDA)
FDA Application
NDA021318FDA Approved
11/26/2002
TE Code
AP
On Market Since
6/3/2025
Pharmacological Classes
Price Statistics
The NADAC for FORTEO 560 MCG/2.24 ML PEN INJ has been published 52 times since Oct 8, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1841.2749 per ML |
|---|---|
| All-time high | $1848.1000 (Feb 11, 2026) |
| All-time low | $1840.3413 (Mar 18, 2026) |
| 52-week high | $1848.1000 |
| 52-week low | $1840.3413 |
| Median price | $1842.2394 |
| Average price | $1843.8573 |
| Largest weekly change | -0.4% (Feb 18, 2026) |
| Weeks tracked | 52 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eli Lilly and Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Teriparatide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Parathyroid Hormone Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FORTEO 560 MCG/2.24 ML PEN INJ?
The current National Average Drug Acquisition Cost (NADAC) for FORTEO 560 MCG/2.24 ML PEN INJ, manufactured by Eli Lilly and Company, is $1841.2749 per ML (NDC 00002967801), effective Sep 30, 2026.
How has the price of FORTEO 560 MCG/2.24 ML PEN INJ changed over time?
Over the history we have for it, the NADAC for FORTEO 560 MCG/2.24 ML PEN INJ has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for FORTEO 560 MCG/2.24 ML PEN INJ?
Since Oct 8, 2025, the NADAC for FORTEO 560 MCG/2.24 ML PEN INJ has ranged from a low of $1840.3413 (Mar 18, 2026) to a high of $1848.1000 (Feb 11, 2026), with a median of $1842.2394 per ML.
Are there cheaper alternatives to FORTEO 560 MCG/2.24 ML PEN INJ?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TERIPARATIDE 560 MCG/2.24 ML PEN, is $479.9511 per ML — about 74% below FORTEO 560 MCG/2.24 ML PEN INJ.
Who manufactures FORTEO 560 MCG/2.24 ML PEN INJ?
FORTEO 560 MCG/2.24 ML PEN INJ (NDC 00002967801) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.